This product consists of a CRISPR/Cas9-edited polyclonal knockout cell population derived from the A-549 human lung adenocarcinoma cell line with targeted disruption of the ANKH gene. The polyclonal format provides a heterogeneous pool of knockout cells, enabling robust loss-of-function studies without clonal bias. The ANKH gene encodes an essential transmembrane transporter of inorganic pyrophosphate (PPi), and its disruption serves as a powerful tool for investigating extracellular PPi dynamics, biomineralization, and calcification-regulatory pathways in a cancer-relevant epithelial background.
The A-549 parental cell line originates from a 58-year-old Caucasian male with lung adenocarcinoma and displays an adherent epithelial morphology. This KRAS-mutant, p53 wild-type line recapitulates key features of type II pneumocytes and is widely employed as a model system for non-small cell lung cancer (NSCLC) biology, tumor microenvironment interactions, and epithelial cell signaling. The retention of functional p53 and the presence of an oncogenic KRAS driver make A-549 cells particularly useful for dissecting crosstalk between oncogenic signaling and microenvironmental calcification processes upon ANKH loss.
ANKH functions as a transmembrane channel that exports intracellular PPi into the extracellular matrix, where PPi acts as a potent inhibitor of hydroxyapatite crystal nucleation and growth. This activity is central to the ENPP1-ANKH-TNAP axis, which tightly regulates the balance between extracellular PPi and inorganic phosphate (Pi). ANKH activity is stimulated by upstream signals such as BMP-2 and TGF-??1 and is subject to modulation by inflammatory cytokines including IL-1?? and TNF??. Downstream, ANKH-mediated PPi efflux suppresses TNAP enzymatic activity and limits hydroxyapatite formation, while also influencing the expression of osteopontin and collagen X. Key molecular partners include ENPP1, which generates extracellular PPi; TNAP, which hydrolyzes PPi to Pi; and the phosphate importer SLC20A1 (PiT-1). Together, these interactions coordinate the mineralization competency of the extracellular milieu within BMP- and Wnt/??-catenin?Cresponsive cellular contexts.
In the A-549 lung adenocarcinoma background, ANKH knockout uncovers a unique intersection between oncogenic signaling and ectopic calcification. Lung cancer cells often reside in a microenvironment prone to aberrant matrix deposition, and loss of ANKH-dependent PPi transport is predicted to lower extracellular PPi levels, thereby removing a critical brake on calcium phosphate crystallization. This model allows researchers to explore how KRAS-driven tumor cells modulate local biomineralization, potentially contributing to tumor-associated calcification or altered stromal interactions. Moreover, since A-549 cells express components of BMP and Wnt pathways, this knockout system can be interrogated for pathway-dependent feedback loops linking mineral metabolism to proliferative and migratory cancer phenotypes.
Representative applications include high-content screening for calcification inhibitors, quantitative assessment of intra- and extracellular PPi pools, real-time monitoring of hydroxyapatite deposition by Alizarin Red S staining, and TNAP enzymatic activity profiling. The polyclonal population is well-suited for RNA-seq transcriptomic analysis to identify global gene expression changes downstream of disrupted PPi transport, as well as for functional rescue experiments using ANKH wild-type overexpression. This model also enables investigation of osteoarthritis and chondrocalcinosis pathomechanisms in an epithelial context, providing a versatile platform for both basic and translational biomineralization research. For technical inquiries and customization options, please contact Ascent Research.
